European Intellectual
Property Institutes Network (EIPIN)
Patenting and the Life
Sciences
Queen Mary Intellectual
Property Research Institute (QMIPRI)
London, 6 - 8 May 2004
Thursday 6 May
Arrivals
Alicante : LGW 1330 hrs (Coach)
Zurich : LHR 1305 hrs (Coach)
Strasbourg : LGW 1250 hrs (Coach)
Coach from Airport to Venue
Venue : Drapers
Lecture Theatre
Queen
Mary, University of London, Mile End Road, London E1 4NS
1530-1600 Registration and Refreshments, Bar Med
1600-1615 Welcome & Chairperson : Dr Gail Evans, Head of Intellectual Property
Research Institute, Queen Mary, University of London
1615-1645 IP Origins of the European
Life-sciences Industries
Dr Graham Dutfield, Reader, QMIPRI
(Author: Intellectual Property Rights and the Life
Science Industries: A twentieth century history (Ashgate, 2002))
1645-1715 Questions and Discussion (Teams 5 &
7)
1715-1845 Team Presentations : 8 teams
involved
1845-1915 Team Preparation (Moot Court
& Reports)
1915 Dinner, “Gallery Restaurant”
Queen Mary, University of London, Mile End
Friday 7 May
Biotechnology Litigation in Europe
Chairperson: Mr Mariano Ricchieri, General Programme Manager,
Magister Lvcentinvs
0930-1015
The Biotechnology Directive
Dr Penny Gilbert, Partner,
BioPharma Group,
Bristows, London
1015-1045 Questions & Discussion (Teams
6 & 8)
1045-1115 Break, Bar Med
Chairperson: Mr Duncan Matthews, Senior Lecturer, Queen Mary Intellectual
Property Research Institute
1115-1150 ‘Harvard Oncomouse’ in Europe
Andrew Sharples and
Duncan Curley,
McDermott, Will and
Emery, London
1150-1215 Questions & Discussion (Team 4)
1215-1255 Stem Cell Patenting - The
University of Edinburgh Case
George Schlich, Partner,
Mathys & Squire, London
1255-1315 Questions & Discussion (Team 3)
1315-1430 Lunch, Gallery Restaurant
Substantive Patents Law
Chairperson: Dr Herbert Laederach, Programme Manager, NDS IP
1430-1500 Unity of Invention and Sufficiency
of Disclosure
Alison Blakey, European
Patent Attorney, Prosidion Ltd, Oxford
1500-1530 Narrow trousers
and narrow patents, a health risk? Full
product protection or purpose-bound
protection for biotechnological inventions
Dr Sven Bostyn, University of Amsterdam
1530-1600 Questions & Discussion (Teams
1 & 12)
1600-1630 Break, Bar Med
1630-1730 Team Presentations (5 teams involved)
1800 Coach from Queen Mary,
University of London, Mile End
1900 Dinner - Queen Mary, River
Thames
2230 Coach return to Queen Mary,
University of London, Mile End
Saturday 8 May 2004
Managing and Exploiting IP in the Life
Sciences
Chairperson: Professor Michael Blakeney, Director, Queen Mary
Intellectual Property Research Institute
0900-0930 Valuation of IP in Biotechnology
and Pharmaceuticals
Dr Markus Reitzig, The Copenhagen Business
School, Department of Industrial Economics and Strategy and LEFIC Center for
Law and Economics, Copenhagen/Frederiksberg
0930-0950 Questions & Discussion (Teams 11
& 13)
0950-1030 Research and the Research
Exception
Trevor Cook
Partner and Joint Head of the Life Sciences Group,
Bird & Bird
1030-1100 Questions & Discussion (Teams 10
& 15)
1100-1130 Break, Bar Med
Chairperson: Professor Gerard Hertig, NDS, IP
1130-1230
Moot Court - The Pleadings
The Judgement
(Team 2, 14 & 16)
1230-1345 Lunch, Gallery Restaurant
Chairperson: Ms Alison Firth, Senior Lecturer, Queen Mary Intellectual
Property Research Institute
1345-1415 Intellectual Property and the
Pharmaceutical Data Exclusivity in the Context of EU Enlargement
Dr Meir P Pugatch,
Consultant,
IP Policy and Commercialization of Knowledge Assets
1415-1445 Questions & Discussion (Team 9)
1445-1515
Graduation Ceremony
1530 Break,
Bar Med (Strasbourg Group, Speakers)
1530 Coach
from Mile End to Airport (Alicante &
Zurich Groups)
Departures : Alicante : LGW 1835 (Coach);
Zurich : LHR 1835 (Coach)
Sunday 9 May
1230 Coach
from Mile End to London Heathrow (Strasbourg Group)
Sunday 9 May Strasbourg : LHR 1600
(Coach)